Remove 2018 Remove Prescription Remove Safety
article thumbnail

Everything You Need to Know About Prior Authorizations in Healthcare

Referral MD

Patient Safety Prior authorization protects patients by: Verifying that prescribed medications or treatments are safe. Prescription drugs with high misuse potential. According to a 2018 AMA survey, 26% of healthcare providers reported waiting three days or more for a decision, highlighting the need for improvements in efficiency.

article thumbnail

Botanical drugs – what is the best way forward for regulatory and market approval?

European Pharmaceutical Review

1 For use as prescription drugs, a botanical product must be approved by the FDA: to date, only two have gained this approval. 10 Evidence of safety, adherence to appropriate manufacturing standards and provision of appropriate product information to users is also required to gain registration under the scheme. 2012/1916). 2012/1916).

Marketing 103
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Clinical trials and pregnancy: regulators weigh in

Clarivate

How feasible is it to establish a drug’s safety for use in a population that may be unwilling or unable to participate in clinical trials? The health of pregnant people and their fetuses can be compromised if the dose/dosing regimen, safety, and efficacy of treatments used during pregnancy are not established.

article thumbnail

Prior Authorization: Why It’s Essential in Healthcare

Referral MD

Patient safety Patient safety is paramount. According to the 2018 American Medical Association (AMA) Prior Authorization Physician Survey, 26% of providers reported waiting three days or more for a prior authorization decision from health plans. b) If there’s a more cost-efficient way to perform the procedure.

article thumbnail

Curavit’s crystal ball – how will 2023 drive meaningful changes in clinical research

pharmaphorum

We will see continued increases in remote clinical trial activities and services in 2023, such as remote monitoring, remote site staff training, remote site activation visits, remote quality management meetings, remote safety management meeting,s and more. 2018 Jul 5;1:27. November 2, 2018. NPJ Digit Med. Chapman, J. Reed, D.

FDA 97
article thumbnail

Mainland China’s regulatory evolution brings greater access to novel drugs

Clarivate

Mainland China has streamlined regulatory protocols for testing and approving prescription drugs in recent years, making dozens of urgently needed treatments, from domestic and international manufacturers alike, available to patients in the process. 3] First list of overseas new drugs urgently needed in clinical practice , November 2018. [4]

article thumbnail

FDA proposes new model for easy-to-understand prescription guides

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has proposed a new model for prescription medication guides for brand name and generic drugs, to increase accessibility and reduce medication nonadherence. The agency describes the current system as “confusing, conflicting, incomplete, or repetitive”, based on study data.